• US Stocks
  • Pfizer Inc.
Market opening in 10 hours 58 minutes
Pfizer Inc.

Pfizer Inc.

HealthcareLarge Cap 
  • $ 40.18

    Stock Price

  • $ 0.17(0.43%)

    Last Change

About the company

Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Viagra, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that will lose or have lost marketing patent protection; branded generic products; sterile injectable products; biosimilars; and infusion systems. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, and Pristiq brand names. This segment also engages in contract manufacturing business. The company has licensing agreements with Cellectis SA and AstraZeneca plc; and collaborative agreements with Eli Lilly & Company and Merck KGaA. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

View More

    Total Revenue

    $ 27.742 B

    Cost of Revenue

    $ 8.648 B

    Gross Profit

    $ 19.094 B

    Operating Income

    $ 12.409 B

Scripbox Recommended US Equity Funds
Want to get exposure to US Equity with the ease of Mutual Funds?Learn more

Price chart

$ 40.49

1D High

$ 40.01

1D Low

$ 0.17 (0.43%)

1D Change

Last updated on Thu 23rd Mar 2023 07:59:58 IST

Previous Close

$ 40.01

Open Price

$ 40.17

52 Week High

$ 54.46

52 Week Low

$ 39.23

PE Ratio




Avg. Volume


Market Cap

$ 226.792 B



Stock NameStock Price52 Week High52 Week LowCapital
AstraZeneca PLC
AstraZeneca PLC
$ 66.57$ 71.09$ 51.90Large Cap
$ 82.53$ 90.33$ 71.00Large Cap
$ 66.96$ 80.80$ 64.94Large Cap
$ 233.17$ 292.06$ 219.83Large Cap
$ 97.02$ 122.66$ 92.83Large Cap
$ 155.56$ 181.77$ 151.23Large Cap
$ 332.70$ 383.20$ 273.35Large Cap
$ 35.23$ 56.49$ 27.92Large Cap
$ 104.23$ 114.69$ 77.39Large Cap

Recent News


Frequently Asked Questions

What is the price of Pfizer Inc. share today in India?

Today, on 24th Mar 2023, the price of Pfizer Inc. Shares in India is $ 40.18.

What was the highest Pfizer Inc. share stock price?

The highest Pfizer Inc. stock price was $ 54.46 till 24th Mar 2023 within the past 52 weeks.

What is the lowest price of PFE shares?

The lowest PFE stock price was $ 39.23 on 24th Mar 2023 within the past 52 weeks.

How to buy PFE shares in India?

You can buy PFE shares in India through Scripbox in just 4 simple steps. The process is simple, seamless, and paperless.
  • Create an account and submit KYC documents
  • On successful KYC, transfer amount required for investment
  • Invest in US stocks
  • Track and manage investments through Scripbox dashboard

Is Pfizer Inc. shares Listed on NSE or BSE?

No, PFE shares are not listed on NSE or BSE. Pfizer Inc. is listed on the NASDAQ stock exchange.

Can I buy Pfizer Inc. shares in India?

Yes, you can buy Pfizer Inc. shares in India by simply opening an account with Scripbox.

Can I buy fractional shares of Pfizer Inc.?

Yes, you can buy fractional shares of Pfizer Inc. with Scripbox.

What is the P/E ratio for Pfizer Inc. shares?

As on 24th Mar 2023, the P/E ratio for Pfizer Inc. shares is 7.35.

What is the traded volume of Pfizer Inc. shares?

As on 24th Mar 2023, the traded volume for Pfizer Inc. shares is 16.929 M.

What is the market capitalization of Pfizer Inc. shares?

Pfizer Inc. shares has a market capitalization of $ 226.792 B.